PortalPublikationenCompeting-risks analysis in patients with T1 squamous cell c...

Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis.

Standard

Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis. / Thuret, Rodolphe; Sun, Maxine; Abdollah, Firas; Budäus, Lars; Shariat, Shahrokh F; Iborra, François; Guiter, Jacques; Patard, Jean-Jacques; Karakiewicz, Pierre I.

in: BJU INT, Jahrgang 111, Nr. 4 Pt B, 4 Pt B, 2013, S. 174-179.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Thuret, R, Sun, M, Abdollah, F, Budäus, L, Shariat, SF, Iborra, F, Guiter, J, Patard, J-J & Karakiewicz, PI 2013, 'Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis.', BJU INT, Jg. 111, Nr. 4 Pt B, 4 Pt B, S. 174-179. <http://www.ncbi.nlm.nih.gov/pubmed/23057865?dopt=Citation>

APA

Thuret, R., Sun, M., Abdollah, F., Budäus, L., Shariat, S. F., Iborra, F., Guiter, J., Patard, J-J., & Karakiewicz, P. I. (2013). Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis. BJU INT, 111(4 Pt B), 174-179. [4 Pt B]. http://www.ncbi.nlm.nih.gov/pubmed/23057865?dopt=Citation

Vancouver

Thuret R, Sun M, Abdollah F, Budäus L, Shariat SF, Iborra F et al. Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis. BJU INT. 2013;111(4 Pt B):174-179. 4 Pt B.

Bibtex

@article{5d7fd0db1d8d4cd5a91180249a0e212a,
title = "Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis.",
abstract = "To quantify and compare cancer-specific mortality (CSM) and other-cause mortality (OCM) in individuals with stage T1G1-3 clinically node-negative (cN0) squamous cell carcinoma of the penis (SCCP) since there is no consensus regarding the need for an inguinal lymph node dissection (ILND) in patients with T1G2-3 cN0 SCCP.",
keywords = "Adult, Humans, Male, Aged, Middle Aged, Aged, 80 and over, United States/epidemiology, Risk Assessment/*methods, Survival Rate/trends, Carcinoma, Squamous Cell/*mortality/pathology, Neoplasm Staging/*methods, Penile Neoplasms/*mortality/pathology, *SEER Program, Adult, Humans, Male, Aged, Middle Aged, Aged, 80 and over, United States/epidemiology, Risk Assessment/*methods, Survival Rate/trends, Carcinoma, Squamous Cell/*mortality/pathology, Neoplasm Staging/*methods, Penile Neoplasms/*mortality/pathology, *SEER Program",
author = "Rodolphe Thuret and Maxine Sun and Firas Abdollah and Lars Bud{\"a}us and Shariat, {Shahrokh F} and Fran{\c c}ois Iborra and Jacques Guiter and Jean-Jacques Patard and Karakiewicz, {Pierre I}",
year = "2013",
language = "English",
volume = "111",
pages = "174--179",
journal = "BJU INT",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "4 Pt B",

}

RIS

TY - JOUR

T1 - Competing-risks analysis in patients with T1 squamous cell carcinoma of the penis.

AU - Thuret, Rodolphe

AU - Sun, Maxine

AU - Abdollah, Firas

AU - Budäus, Lars

AU - Shariat, Shahrokh F

AU - Iborra, François

AU - Guiter, Jacques

AU - Patard, Jean-Jacques

AU - Karakiewicz, Pierre I

PY - 2013

Y1 - 2013

N2 - To quantify and compare cancer-specific mortality (CSM) and other-cause mortality (OCM) in individuals with stage T1G1-3 clinically node-negative (cN0) squamous cell carcinoma of the penis (SCCP) since there is no consensus regarding the need for an inguinal lymph node dissection (ILND) in patients with T1G2-3 cN0 SCCP.

AB - To quantify and compare cancer-specific mortality (CSM) and other-cause mortality (OCM) in individuals with stage T1G1-3 clinically node-negative (cN0) squamous cell carcinoma of the penis (SCCP) since there is no consensus regarding the need for an inguinal lymph node dissection (ILND) in patients with T1G2-3 cN0 SCCP.

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Middle Aged

KW - Aged, 80 and over

KW - United States/epidemiology

KW - Risk Assessment/methods

KW - Survival Rate/trends

KW - Carcinoma, Squamous Cell/mortality/pathology

KW - Neoplasm Staging/methods

KW - Penile Neoplasms/mortality/pathology

KW - SEER Program

KW - Adult

KW - Humans

KW - Male

KW - Aged

KW - Middle Aged

KW - Aged, 80 and over

KW - United States/epidemiology

KW - Risk Assessment/methods

KW - Survival Rate/trends

KW - Carcinoma, Squamous Cell/mortality/pathology

KW - Neoplasm Staging/methods

KW - Penile Neoplasms/mortality/pathology

KW - SEER Program

M3 - SCORING: Journal article

VL - 111

SP - 174

EP - 179

JO - BJU INT

JF - BJU INT

SN - 1464-4096

IS - 4 Pt B

M1 - 4 Pt B

ER -